SplitApr 22, 2026, 08:39 AM
Cue Biopharma Announces 1-for-30 Reverse Stock Split
AI Summary
Cue Biopharma, Inc. announced a 1-for-30 reverse stock split, effective April 23, 2026, with split-adjusted trading commencing on April 24, 2026. This action, approved by stockholders and determined by the Board, aims to increase the per-share market price to meet Nasdaq's minimum bid price requirement for continued listing. The split will reduce outstanding shares from approximately 97.7 million to 3.3 million, with proportional adjustments to stock options and warrants.
Key Highlights
- 1-for-30 reverse stock split effective April 23, 2026.
- Trading on split-adjusted basis begins April 24, 2026.
- Outstanding shares reduced from 97.7 million to 3.3 million.
- Aims to regain Nasdaq minimum bid price compliance.